SCHEMBL10233175

SCHEMBL10233175

CCC(Sc1ccc(O)cc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.46
HSD17B10 Q99714 1/20 0.46
ESR1 P03372 4/20 0.42
MAPT P10636 2/20 0.42
CYP1A2 P05177 1/20 0.42
PGR P06401 1/20 0.42
CHRM2 P08172 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
AR P10275 1/20 0.42
CYP2D6 P10635 1/20 0.42
CHRM1 P11229 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX15 P16050 1/20 0.42
DRD1 P21728 1/20 0.42
TBXA2R P21731 1/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42
CYP2C19 P33261 1/20 0.42
ADRA1A P35348 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3234111 0.91 ESR1 (0.52) LMNAESR1MAPTCYP1A2PGR
SCHEMBL8379408 0.87 ALDH1A1 (0.46) LMNAMAPTTDP1ALDH1A1KDM4E
SCHEMBL16596846 0.84 ALDH1A1 (0.44) LMNAMAPTTDP1ALDH1A1KDM4E
SCHEMBL8948484 0.84 LMNA (0.40) LMNAHSD17B10ESR1CYP2D6CYP2C9
SCHEMBL3234656 0.76 ESR1 (0.47) LMNAESR1MAPTCYP1A2PGR
SCHEMBL16596820 0.76 PPARG (0.54) CYP1A2CYP2D6CYP2C9CYP2C19CYP19A1
SCHEMBL10234305 0.76 DAO (0.51) LMNAHSD17B10ESR1CYP2D6CYP2C9
SCHEMBL12427037 0.75 IDO1 (0.42) LMNAHSD17B10ESR1CYP1A2CYP3A4
SCHEMBL361277 0.72 LMNA (0.58) LMNAHSD17B10ESR1MAPTCYP1A2
SCHEMBL4960257 0.72 ESR1 (0.46) LMNAHSD17B10ESR1MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120034559-A1 ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM THEREFROM AND METHOD OF FORMING PATTERN THEREWITH FUJIFILM CORPORATION (JP) 2012-02-09 US disclosed
US-20110159433-A1 PHOTOSENSITIVE COMPOSITION, PATTERN-FORMING METHOD USING THE COMPOSITION, AND RESIN USED IN THE COMPOSITION FUJIFILM CORPORATION (JP) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110159433-A1 PHOTOSENSITIVE COMPOSITION, PATTERN-FORMING METHOD USING THE COMPOSITION, AND RESIN USED IN THE COMPOSITION SUN2, LCP1, PHYKPL LMNA 1348/4885HSD17B10 3423/4885ESR1 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.